Something Is Golden in the State of Denmark
Over the past couple of years, no new pharmaceutical drug—perhaps no product, period—has had such widespread impact as the diabetes medication Ozempic and the weight-loss drug Wegovy, both made by Danish company Novo Nordisk. Most obviously, the drugs have changed the lives of the millions of people who now count on them to help control their appetite. These two products have taken Novo Nordisk from a successful but second-tier drugmaker to the most valuable company in Europe.
The drugs are also having ripple effects across the business world. To take one example, snack and soda makers have wondered whether they need to adjust their that the drugs’ popularity might boost airline profits—because their passengers will weigh less in the future.
